James W. Freeman

4.5k citations
92 papers · 3.6k · 1 hit paper · h-index 34

Impact in

Papers in

    • TGF-β signaling in diseases 14
    • RNA modifications and cancer 12
    • Cancer-related gene regulation 7
    • RNA Research and Splicing 5
    • Pancreatic and Hepatic Oncology Research 19
    • Cancer Cells and Metastasis 9
    • Cancer-related Molecular Pathways 7

James W. Freeman

87 papers receiving 3.5k citations

James W. Freeman's Hit Papers

The biology and role of CD44 in cancer progression: therapeutic implications 2018 · 938 citations
9380+2+5Years since publication250500750

Peers

James W. Freeman
Comparison fields: 5 of 128
  • Cancer Research 734
  • Oncology 1.3k
  • Molecular Biology 2.2k
  • Cell Biology 331
  • Immunology 374
Replace Ryoichi Oyasu with:
Ryoichi Oyasu United States
M. Iqbal Parker South Africa
Surinder K. Batra United States
José G. Treviño United States
John J. Kavanagh United States
Thilo Spruß Germany
Andrea Nicolini Italy
Guojun Wu China
Audrey Vincent France
Lidija Klampfer United States
James W. Freeman relative to Ryoichi Oyasu United States Ryoichi Oyasu's profile →
Citations per field
00.5×7.6×
Ryoichi Oyasu · 1×
Citations per year

Countries citing papers authored by James W. Freeman

Since Specialization
Citations

This map shows the geographic impact of James W. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Freeman more than expected).

Fields of papers citing papers by James W. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Freeman. The network helps show where James W. Freeman may publish in the future.

Co-authors

The 25 scholars most cited alongside James W. Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James W. Freeman Line = papers co-authored together James W. Freeman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The biology and role of CD44 in cancer progression: therapeutic implications
Hit paper breakdown →
2018938
2 2016129
3 2003113
4 2004111
5 2005105
6 200898
7
Identification and characterization of a human proliferation-associated nucleolar antigen with a molecular weight of 120,000 expressed in early G1 phase.
198894
8 196978
9 199076
10
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
200371
11 200163
12 201461
13
Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
199161
14 201356
15 199554
16 200252
17 199751
18 200351
19 201449
20 201547

About James W. Freeman

James W. Freeman is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Immunology, having authored 92 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (19 papers), TGF-β signaling in diseases (14 papers), RNA modifications and cancer (12 papers), Cancer Cells and Metastasis (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer-related Molecular Pathways (7 papers), Cancer-related gene regulation (7 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (734 citations), Oncology (1.3k citations), Molecular Biology (2.2k citations), Cell Biology (331 citations) and Immunology (374 citations). James W. Freeman has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Shujie Zhao, Anand B. Karnad, Chen Chen, Kolaparthi Venkatasubbarao, Michael G. Brattain, Sudhakar Ammanamanchi, Shujie Zhao, Harris Busch, William E. Strodel and Carol Swiderski. Their work appears in journals such as Journal of Biological Chemistry, Journal of Cellular Physiology, Cancer Research, Cytometry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact